Drugs / POTASSIUM MAGNESIUM CITRATE (4:1:2)
POTASSIUM MAGNESIUM CITRATE (4:1:2)
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 11 trial | ||||||
| Phase 1 | NCT06819111 | Jul 2026 → Jul 2027 expected | nephrolithiasis | University of Texas Southwestern Medical Center | Not yet recruiting | No outcome recorded |
| Phase 1/21 trial | ||||||
| Phase 1/2 | NCT01074918 | Sep 2009 → Sep 2012 | hypertensive disorder | University of Texas Southwestern Medical Center | Withdrawn | No outcome recorded Stop: Enrollment |
| Phase 21 trial | ||||||
| Phase 2 | NCT05145309 | Nov 2026 → Dec 2031 expected | hypertensive disorder | University of Texas Southwestern Medical Center | Not yet recruiting | No outcome recorded |
| Phase 41 trial | ||||||
| Phase 4 | NCT02653560 | Sep 2012 → Jan 2015 | hypertensive disorder | University of Texas Southwestern Medical Center | Completed | No outcome recorded |
| Comparator or background therapy1 trial | ||||||
| — | NCT02665117 Comparator | Jan 2015 → Nov 2022 | hypertensive disorder | University of Texas Southwestern Medical Center | Completed | No outcome recorded |
Evidence & citations 8 cited values
Every value below carries the sentence it was read from. 6 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | POTASSIUM MAGNESIUM CITRATE (4:1:2) | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314426 ↗ |
| Known as | Hcactive | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314426 ↗ |
| Known as | K-mag | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314426 ↗ |
| Known as | KMgCit | “Drug: Potassium magnesium Citrate (KMgCit)” NCT02653560 ↗ |
| Known as | Potassium-Magnesium Citrate | “Patients will receive slow-release potassium citrate (UroCit-K), potassium magnesium citrate (powder), or potassium magnesium citrate (tablets).” NCT06819111 ↗4“Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients” NCT01074918 ↗ “Potassium-Magnesium Citrate as a Blood Pressure Lowering Agent in Hypertensive Patients” NCT01074918 ↗ |
| Known as | Relyte | ChEMBL registry synonym — accepted as the source's own label CHEMBL5314426 ↗ |
| Modality | Small molecule | — CHEMBL5314426 ↗ |
| Route | Oral | “will be drunk with breakfast and again with dinner during the KMgCit Phase” NCT02653560 ↗ |